Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.

    Williams KJ, Liu ML, Zhu Y, Xu X, Davidson WR, McCue P, Sharma K.

    Diabetes. 2005 Apr;54(4):1116-22.PMID: 15793251 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.

    Ottlecz A, Bensaoula T, Eichberg J, Peterson RG.

    Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2157-64.PMID: 8843902 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns.

    Pikas DS, Eriksson I, Kjellén L.

    Biochemistry. 2000 Apr 18;39(15):4552-8.PMID: 10758005 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.

    van den Born J, Pikas DS, Pisa BJ, Eriksson I, Kjellen L, Berden JH.

    Glycobiology. 2003 Jan;13(1):1-10. Epub 2002 Nov 1.PMID: 12634318 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.

    Kidney Int Suppl. 2005 Dec;(99):S98-102.PMID: 16336586 [PubMed - indexed for MEDLINE]Related articles

    6.

    Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.

    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.

    J Lab Clin Med. 2004 Feb;143(2):106-14.PMID: 14966466 [PubMed - indexed for MEDLINE]Related articles

    7.

    Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).

    Tarsitano CA, Paffaro VA Jr, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.

    Cell Tissue Res. 2007 Jul;329(1):45-58. Epub 2007 Apr 14.PMID: 17436021 [PubMed - indexed for MEDLINE]Related articles

    8.

    Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation.

    Ledin J, Ringvall M, Thuveson M, Eriksson I, Wilén M, Kusche-Gullberg M, Forsberg E, Kjellén L.

    J Biol Chem. 2006 Nov 24;281(47):35727-34. Epub 2006 Sep 19.PMID: 16984905 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Identification of angiotensin converting enzyme 2 in the rodent retina.

    Tikellis C, Johnston CI, Forbes JM, Burns WC, Thomas MC, Lew RA, Yarski M, Smith AI, Cooper ME.

    Curr Eye Res. 2004 Dec;29(6):419-27.PMID: 15764086 [PubMed - indexed for MEDLINE]Related articles

    10.

    ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.

    Schmeisser A, Soehnlein O, Illmer T, Lorenz HM, Eskafi S, Roerick O, Gabler C, Strasser R, Daniel WG, Garlichs CD.

    Biochem Biophys Res Commun. 2004 Dec 10;325(2):532-40.PMID: 15530425 [PubMed - indexed for MEDLINE]Related articles

    11.

    Distinct effects on heparan sulfate structure by different active site mutations in NDST-1.

    Bengtsson J, Eriksson I, Kjellén L.

    Biochemistry. 2003 Feb 25;42(7):2110-5.PMID: 12590599 [PubMed - indexed for MEDLINE]Related articles

    12.

    Disturbed Ca2+ kinetics in N-deacetylase/N-sulfotransferase-1 defective myotubes.

    Jenniskens GJ, Ringvall M, Koopman WJ, Ledin J, Kjellén L, Willems PH, Forsberg E, Veerkamp JH, van Kuppevelt TH.

    J Cell Sci. 2003 Jun 1;116(Pt 11):2187-93. Epub 2003 Apr 8.PMID: 12692154 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.

    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.

    Eur J Pharmacol. 2005 Jun 15;516(3):253-9.PMID: 15963975 [PubMed - indexed for MEDLINE]Related articles

    14.

    Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.

    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.

    Am J Physiol Renal Physiol. 2005 Oct;289(4):F911-21. Epub 2005 Jun 7.PMID: 15942051 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors]

    Yoshikawa H.

    Nippon Jinzo Gakkai Shi. 1999 Aug;41(5):486-92. Japanese. PMID: 10502942 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Expression of N-deacetylase/N-sulfotransferase (NDST) during early rat embryogenesis]

    Ikeda M.

    Kokubyo Gakkai Zasshi. 2001 Jun;68(2):184-92. Japanese. PMID: 11496407 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

    Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME.

    Hypertension. 2003 Mar;41(3):392-7. Epub 2003 Feb 24.PMID: 12623933 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2.

    Duncan MB, Liu M, Fox C, Liu J.

    Biochem Biophys Res Commun. 2006 Jan 27;339(4):1232-7. Epub 2005 Dec 6.PMID: 16343444 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data